Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|August 12, 1999
Some international approaches to aminoglycoside monitoring in the extended dosing interval eraR G Morris, B C Sallustio, A A Vinks, et al.
Therapeutic Drug Monitoring|March 2, 1999
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysisN A van Lent-Evers, R A Mathôt, W P Geus, et al.
Critical Care Medicine|July 9, 2003
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patientsS N de Wildt, M de Hoog, A A Vinks, et al.
The Pharmacogenomics Journal|January 27, 2016
ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in childrenV Chidambaran, R Venkatasubramanian, X Zhang, et al.
Therapeutic Drug Monitoring|December 22, 1999
Can tobramycin inhalation be improved with a jet nebulizer?P P Le Brun, A A Vinks, D J Touw, et al.
Cancer Chemotherapy and Pharmacology|April 8, 2004
Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755A M E Bos, K Boom, A A Vinks, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipientsS E Prausa, T Fukuda, D Maseck, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 13, 2013
An integrated population pharmacokinetic meta-analysis of propofol in morbidly obese and nonobese adults, adolescents, and childrenJ Diepstraten, V Chidambaran, S Sadhasivam, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patientsP P H Le Brun, A H de Boer, G P M Mannes, et al.
Clinical Pharmacology and Therapeutics|March 25, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus DosingK A Birdwell, B Decker, J M Barbarino, et al.
Pageof 5